TUSTIN, Calif., March 03, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the third quarter of fiscal year 2020 on?March 10, 2020?after market close and will host a conference call and webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).? Members of Avid’s senior management will discuss financial results for the third quarter and review recent corporate developments.
News Ticker
- [ December 6, 2023 ] CatalYm’s efforts to revive obesity target for solid tumors yield positive PhIIa results Los Angeles Biotech News
- [ December 6, 2023 ] Latino Alternative Television (LATV) Partners with the Huntsman Mental Health Institute and the Ad Council for Latino Men’s Mental Health Event Los Angeles Biotech News
- [ December 6, 2023 ] Deep 6 AI Expands Its Recruitment Acceleration Solution for Life Sciences to Shorten the Time from Determining Patient Eligibility to Enrollment Los Angeles Biotech News
- [ December 6, 2023 ] Lab operation Manager – MolBreeding biotechnology LLC – Irvine, CA Los Angeles Biotech Jobs
- [ December 6, 2023 ] SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability Los Angeles Biotech News
Copyright © 2023 Biotech Networks, LLC
